References
- First COVID-19 case happened in November, China government records show – report. [cited 2020 Nov 28]. https://www.theguardian.com/world/2020/mar/13/first-COVID-19-case-happened-in-november-china-government-records-show-report
- Gov.UK Coronavirus 2019 COVID-19) in the UK. [cited 2020 Nov 28]. https://coronavirus.data.gov.uk/
- Intensive Care National Audit & Research Center. COVID-19 report. [cited 2020 Dec 9]. https://www.icnarc.org/Our-Audit/Audits/Cmp/Reports
- Office for National Statistics. COVID-19 positivity rates by age. [cited 2020 Nov 28]. https://www.ons.gov.uk/aboutus/transparencyandgovernance/freedomofinformationfoi/covid19positivityratesbyage
- Atkins JL, Masoli JAH, Delgado J, et al. Preexisting comorbidities predicting COVID-19 and mortality in the UK biobank community cohort. J Gerontol A Biol Sci Med Sci. 2020;75(11):2224–2230.
- Yang H-C, Chen C-H, Wang J-H, et al. Analysis of genomic distributions of SARS-CoV-2 reveals a dominant strain type with strong allelic associations. PNAS. 2020;117(48):30679–30686.
- Collaborative Group RECOVERY, Horby P, Lim WS, et al. Dexamethasone in hospitalized patients with COVID-19- preliminary report. N Engl J Med. 2020. doi: 10.1056/NEJMoa2021436.
- WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne JAC, Murthy S, Diaz J.V., et al. Association between administration of systemic corticosteroids and mortality among critically Ill patients with COVID-19: a meta-analysis. JAMA 2020;324(13):1330–1341.
- Hasan SS, Capstick T, Ahmed R, et al. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med. 2020 Nov;14(11):1149–1163. doi: 10.1080/17476348.2020.1804365
- Keeley AJ, Evans CM, De Silva TI. Asymptomatic SARS-CoV-2 infection: the tip or the iceberg? Thorax. 2020;75:621–622.
- Plackett B. Why big pharma has abandoned antibiotics: No money for new drugs. Nature. 2020;586(7830):S50–2.
- World Health Organisation, 2020. Lack of new antibiotics threatens global efforts to contain drug-resistant infections. [cited 2020 Dec 9]. https://www.who.int/news/item/17-01-2020-lack-of-new-antibiotics-threatens-global-efforts-to-contain-drug-resistant-infections
- Association of Business Pharmaceutical Industry UK, 2020. $1 billion antibiotics research fund launched by pharmaceutical companies. [cited 2021 Jan 17]. https://www.abpi.org.uk/media-centre/news/2020/july/1-billion-antibiotics-research-fund-launched-by-pharmaceutical-companies/
- Furuta Y, Komeno T, Favipiravir NT. T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(7):449–463.
- Shiraki K, Daikoku T. Favipiravir, an anti-influenza drug against life-threatening RNA virus infections. Pharmacology & Therapeutics. 2020;209:107512. .
- Sheahan TP, Sims AC, Zhou S, et al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci Transl Med. 2020;12(541):541.
- Cox RM, Wolf JD, Plemper RK. Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets. Nat Microbiol. 2020;209(1):11–18.